These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 15159377

  • 21. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 22. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
    Hart M, Thakral B, Yohe S, Balfour HH, Singh C, Spears M, McKenna RW.
    Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
    [Abstract] [Full Text] [Related]

  • 23. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD.
    D'Antiga L, Del Rizzo M, Mengoli C, Cillo U, Guariso G, Zancan L.
    Liver Transpl; 2007 Mar; 13(3):343-8. PubMed ID: 17154402
    [Abstract] [Full Text] [Related]

  • 24. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.
    Leung E, Shenton BK, Green K, Jackson G, Gould FK, Yap C, Talbot D.
    Transpl Infect Dis; 2004 Dec; 6(4):156-64. PubMed ID: 15762933
    [Abstract] [Full Text] [Related]

  • 25. Lytic and latent EBV gene expression in transplant recipients with and without post-transplant lymphoproliferative disorder.
    Kroll J, Li S, Levi M, Weinberg A.
    J Clin Virol; 2011 Nov; 52(3):231-5. PubMed ID: 21900040
    [Abstract] [Full Text] [Related]

  • 26. Post-transplantation lymphoproliferative disease: Epstein-Barr virus DNA levels, HLA-A3, and survival.
    Wheless SA, Gulley ML, Raab-Traub N, McNeillie P, Neuringer IP, Ford HJ, Aris RM.
    Am J Respir Crit Care Med; 2008 Nov 15; 178(10):1060-5. PubMed ID: 18755927
    [Abstract] [Full Text] [Related]

  • 27. The value of prospective monitoring of Epstein-Barr virus DNA in blood samples of pediatric liver transplant recipients.
    Scheenstra R, Verschuuren EA, de Haan A, Slooff MJ, The TH, Bijleveld CM, Verkade HJ.
    Transpl Infect Dis; 2004 Mar 15; 6(1):15-22. PubMed ID: 15225222
    [Abstract] [Full Text] [Related]

  • 28. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS.
    Cancer Res; 1981 Nov 15; 41(11 Pt 1):4253-61. PubMed ID: 6272971
    [Abstract] [Full Text] [Related]

  • 29. Soluble CD30: a serum marker for Epstein-Barr virus-associated lymphoproliferative diseases.
    Haque T, Chaggar T, Schafers J, Atkinson C, McAulay KA, Crawford DH.
    J Med Virol; 2011 Feb 15; 83(2):311-6. PubMed ID: 21181928
    [Abstract] [Full Text] [Related]

  • 30. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb 15; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

  • 31. Adenotonsillar hypertrophy and Epstein-Barr virus in pediatric organ transplant recipients.
    Shapiro NL, Strocker AM.
    Laryngoscope; 2001 Jun 15; 111(6):997-1001. PubMed ID: 11404611
    [Abstract] [Full Text] [Related]

  • 32. Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA.
    Kullberg-Lindh C, Olofsson S, Brune M, Lindh M.
    Transpl Infect Dis; 2008 Oct 15; 10(5):308-15. PubMed ID: 18466193
    [Abstract] [Full Text] [Related]

  • 33. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
    Meerbach A, Wutzler P, Häfer R, Zintl F, Gruhn B.
    J Med Virol; 2008 Mar 15; 80(3):441-54. PubMed ID: 18205222
    [Abstract] [Full Text] [Related]

  • 34. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
    Hosseini-Moghaddam SM, Alhomayeed B, Soliman N, Weir MA, House AA.
    Transpl Infect Dis; 2016 Jun 15; 18(3):423-30. PubMed ID: 27016725
    [Abstract] [Full Text] [Related]

  • 35. Epstein-Barr virus, B cell lymphoproliferative disease, and SCID mice: modeling T cell immunotherapy in vivo.
    Johannessen I, Bieleski L, Urquhart G, Watson SL, Wingate P, Haque T, Crawford DH.
    J Med Virol; 2011 Sep 15; 83(9):1585-96. PubMed ID: 21739450
    [Abstract] [Full Text] [Related]

  • 36. Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.
    Doesch AO, Konstandin M, Celik S, Kristen A, Frankenstein L, Sack FU, Schnabel P, Schnitzler P, Katus HA, Dengler TJ.
    Transpl Int; 2008 Oct 15; 21(10):963-71. PubMed ID: 18564989
    [Abstract] [Full Text] [Related]

  • 37. Screening for PTLD in lung and heart-lung transplant recipients by measuring EBV DNA load in bronchoalveolar lavage fluid using real time PCR.
    Michelson P, Watkins B, Webber SA, Wadowsky R, Michaels MG.
    Pediatr Transplant; 2008 Jun 15; 12(4):464-8. PubMed ID: 18466434
    [Abstract] [Full Text] [Related]

  • 38. Decreasing the Epstein-Barr virus load by adjusting the FK506 blood level.
    Orii T, Ohkohchi N, Satomi S, Hoshino Y, Kimura H.
    Transpl Int; 2002 Nov 15; 15(11):529-34. PubMed ID: 12461655
    [Abstract] [Full Text] [Related]

  • 39. Epstein-Barr virus (EBV) early-antigen serologic testing in conjunction with peripheral blood EBV DNA load as a marker for risk of posttransplantation lymphoproliferative disease.
    Carpentier L, Tapiero B, Alvarez F, Viau C, Alfieri C.
    J Infect Dis; 2003 Dec 15; 188(12):1853-64. PubMed ID: 14673764
    [Abstract] [Full Text] [Related]

  • 40. Epstein-Barr viremia levels after pediatric liver transplantation as measured by real-time polymerase chain reaction.
    Kullberg-Lindh C, Ascher H, Saalman R, Olausson M, Lindh M.
    Pediatr Transplant; 2006 Feb 15; 10(1):83-9. PubMed ID: 16499593
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.